Polyrizon (NASDAQ:PLRZ) Issues Quarterly Earnings Results

Polyrizon (NASDAQ:PLRZ) issued its quarterly earnings data on Monday. The company reported ($0.40) earnings per share (EPS) for the quarter, FiscalAI reports.

Polyrizon Trading Up 1.3%

Shares of Polyrizon stock opened at $10.49 on Wednesday. The stock has a 50 day moving average price of $11.50 and a 200-day moving average price of $12.80. Polyrizon has a one year low of $2.88 and a one year high of $18.20.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the stock. Wall Street Zen lowered shares of Polyrizon from a “hold” rating to a “sell” rating in a research note on Saturday, September 12th. Weiss Ratings raised Polyrizon from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, September 18th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Polyrizon has an average rating of “Sell”.

Polyrizon Company Profile

Polyrizon Ltd. is an Israel-based biotechnology company developing hydrogel-based nasal products intended to provide localized protection in the nasal cavity. Its technology is designed to create a physical barrier that may help reduce exposure to airborne pathogens, allergens and other harmful particles before they enter the respiratory system.

The company’s platform focuses on nasal formulations and delivery systems that can adhere to the nasal mucosa and support applications in respiratory health.